Agios Pharmaceuticals (AGIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2006 | |
| Sales | 65,358 | 25,548 | 25,106 | 21,837 | 0 |
| Gross Profit | 65,358 | 25,548 | 25,106 | 21,837 | N/A |
| Operating Expenses | 119,491 | 64,431 | 48,101 | 38,468 | 0 |
| Operating Income | -54,133 | -38,883 | -22,995 | -16,631 | N/A |
| Other Income | 203 | 55 | 69 | 132 | 0 |
| Pre-tax Income | -53,930 | -38,828 | -22,926 | -16,499 | 0 |
| Income Tax | -426 | 579 | -2,824 | 7,207 | N/A |
| Net Income Continuous | -53,504 | -39,407 | -20,102 | -23,706 | N/A |
| Net Income | $-53,504 | $-39,407 | $-20,102 | $-23,706 | $N/A |
| EPS Basic Total Ops | -1.59 | -2.83 | -8.02 | -8.90 | N/A |
| EPS Basic Continuous Ops | -1.59 | -2.56 | -5.91 | -7.87 | N/A |
| EPS Diluted Total Ops | -1.59 | -2.83 | -8.02 | -8.90 | N/A |
| EPS Diluted Continuous Ops | -1.59 | -2.56 | -5.91 | -7.87 | N/A |
| EBITDA(a) | $-52,228 | $-37,159 | $-21,529 | $-15,439 | $N/A |